AzTrials
AzTrials

Dental PainNCT06625853

XP-Endo Finisher on Postoperative Pain in Retreatment Cases Using Mtwo R Files

A study testing Mtwo R files with Xp-Endo finisher file and Mtwo R files in people with Dental Pain and Endodontically Treated Teeth, run by Hams Hamed Abdelrahman at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Introduction: Postoperative pain is one of the most critical issues in our daily practice. , postoperative pain control is essential for patient satisfaction and comfort. When primary root canal treatment fails, root canal retreatment aims to heal apical periodontitis. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dental Pain, Endodontically Treated Teeth
What is being tested?
Mtwo R files with Xp-Endo finisher file and Mtwo R files
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteEgypt
Study dates
12 Sep 2023to 23 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Teeth with mature apices.
  • Patients with no systemic diseases.
  • No analgesic, anti-inflammatory, or antibiotic intake during 7 days before treatment.
  • Teeth showing failure of initial root canal treatment and radiograph evidence of periapical bone destruction

Who cannot join

  • Multi rooted teeth.
  • Teeth with open apices.
  • Teeth with cracks, calcification, root caries, fractures, external or internal resorption.
  • Allergies to local anesthetic agents.
  • Presence of severe pain and/or acute apical abscesses

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Alexandria Faculty of Dentistry

    Alexandria

Other trials in Egypt

About this study

Official title: Supplementary Use of the XP-Endo Finisher on Postoperative Pain in Retreatment Cases Using Mtwo R Files (Randomized Clinical Trial)

Introduction: Postoperative pain is one of the most critical issues in our daily practice. , postoperative pain control is essential for patient satisfaction and comfort. When primary root canal treatment fails, root canal retreatment aims to heal apical periodontitis.

Aim of study: To compare between postoperative pain (POS) after endodontic retreatment using NI-TI rotary files Mtwo R alone and in conjunction with XP endo finisher .

Materials and Methods: This research is a randomized clinical trial conducted in a parallel design on 50 patients needing retreatment. They will be divided into two groups, group 1 retreatment with Mtwo R, group 2 retreatment with Mtwo R followed by Xp - Endo finisher. Postoperative pain levels will be evaluated at 24 hours, 48 hours, 72 hours, and 7 days following the removal of the obturation mat erial. The assessment of pain will be done through clinical examination, The Defense and veterans pain rating scale (DVPRS) and by the intake of pain killer

Being tested
Mtwo R files with Xp-Endo finisher file, Mtwo R files
Medical subject headings
Toothache, Tooth, Nonvital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mtwo R files with Xp-Endo finisher fileOther

    XP-endo Finisher file will be inserted without rotation into the root canals filled with 2.5% NaOCl and will be activated (800 rpm; torque of 1 N.cm) for

    1 min in each canal using slow and gentle 7-8 mm lengthwise movements.

  • Mtwo R filesOther

    obturation material will be removed using Mtwo R (VDW, Munich, Germany)files attached to an endodontic motor (Ecube, seachin, Korea) with a constant speed of 280 rpm, as suggested by the manufacturer. Mtwo R 25/0.05 will be used to empty the coronal and middle thirds of the root. Mtwo R 15/0.05 will be used to reach the working length.

Study groups in NCT06625853
Study groupRoleWhat they receive
Mtwo R files without Xp-endo finisher file.ExperimentalNot described
Receives: Other: Mtwo R files
Mtwo R files followed by Xp-Endo finisher fileExperimentalNot described
Receives: Other: Mtwo R files with Xp-Endo finisher file

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain

    Word descriptors are attached to each number on the DVPRS

    0 = No pain

    1. = Hardly noticeable pain
    2. = Noticeable pain, but does not interfere with activities
    3. = Somewhat distracting pain
    4. = Distracting pain, but does not affect normal activities
    5. = Pain interrupts some activities
    6. = Hard to ignore pain, avoidance of daily activities
    7. = Pain is the main focus of attention, prevents daily activities
    8. = Awful pain, difficult to do anything
    9. = Unbearable pain, cannot do anything
    10. = As bad as pain can be, nothing else matters

    Measured: 24-hours,48-hours,72hours and 7 days

Secondary outcomes (1)
  1. change in analgesics intake according to severity of pain according to WHO Analgesic Ladder

    First Step - Mild pain: non-opioid analgesics such as nonsteroidal antiinflammatory drugs (NSAIDs) or acetaminophen with or without adjuvants.

    • Second Step - Moderate pain: weak opioids (hydrocodone, codeine, tramadol) with or without non-opioid analgesics and with or without adjuvants.
    • Third Step - Severe and persistent pain: potent opioids (morphine, methadone, fentanyl, oxycodone, buprenorphine, tapentadol, hydromorphone, oxymorphone) with or without non-opioid analgesics, and with or without adjuvants.

    Measured: 24-hours,48-hours,72hours and 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2024
  2. Study start12 Sep 2023
  3. Primary completion23 Apr 2024
  4. Study completion23 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06625853
Sponsor's protocol ID
0738-08/2023
Status last verified
Oct 2024
First submitted
1 Oct 2024
Last updated
3 Oct 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Mtwo R files with Xp-Endo finisher file and Mtwo R files in people with Dental Pain and Endodontically Treated Teeth, run by Hams Hamed Abdelrahman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain (time frame: 24-hours,48-hours,72hours and 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in